Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

NCT05978193 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
Esophageal Cancer
Metastatic Esophageal Squamous Cell Carcinoma

Interventions

RADIATION: LDRT+CFRT
DRUG: Immunotherapy
DRUG: Chemotherapy

Sponsor

Shanghai Chest Hospital